Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Individual, Social, and Environmental Factors Associated with Different Patterns of Stimulant Use: A Cross-Sectional Study from Five European Countries

M. Rosenkranz, A. O'Donnell, MS. Martens, H. Zurhold, P. Degkwitz, N. Liebregts, M. Barták, M. Rowicka, U. Verthein

. 2023 ; 29 (3) : 182-193. [pub] 20230425

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24001319

INTRODUCTION: Amphetamine-type stimulants (ATSs) are the second most commonly consumed class of illicit drugs globally, but there is limited understanding of the precise factors associated with problematic versus controlled ATS consumption. This exploratory study aimed to identify which individual, social, and environmental factors are associated with different patterns of ATS use over time. METHODS: Cross-sectional surveys were conducted in Germany, England, The Netherlands, Poland, and the Czech Republic via face-to-face computer-assisted personal interviews to collect data on different user groups. 1,458 adults (18+) reported exposure to but no ATS use (n = 339); former rare/moderate ATS use (n = 242); current rare/moderate ATS use (n = 273); former frequent/dependent ATS use (n = 201); current frequent/dependent ATS use (n = 403). Extent of ATS/other substance use was assessed by number of consumption days (lifetime, past year, past month) and Severity of Dependence Scale. To identify factors associated with group membership, data were also collected on previous injecting drug use (IDU) and consumption setting/rules. Psychological distress was measured using the Brief Symptom Inventory, with additional data collected on self-reported adverse life events and physical/mental health. RESULTS: Currently, using frequent/dependent ATS users experienced more frequent unstable living conditions (27.5%) and psychological distress (59.8%) compared to other groups. A multinomial logistic regression showed that currently abstinent rare/moderate users were more likely to abstain from methamphetamine use {odds ratio (OR) = 2.48 (confidence interval [CI] = 1.32-4.68)} and from IDU (OR = 6.33 [CI = 2.21-18.14]), to avoid ATS use during working hours (OR = 6.67 [CI = 3.85-11.11]), and not to use ATS for coping reasons (OR = 4.55 [CI = 2.50-6.67]) compared to the reference group of currently using frequent/dependent users. CONCLUSIONS: People who use ATS frequently and/or at dependent levels are more likely to have experienced social and economic adversity compared to infrequent ATS users. On the other hand, there is a substantial share of users, which show a controlled use pattern and are able to integrate ATS use into their lives without severe consequences.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001319
003      
CZ-PrNML
005      
20240213094539.0
007      
ta
008      
240109s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000529944 $2 doi
035    __
$a (PubMed)37166303
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Rosenkranz, Moritz $u Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
245    10
$a Individual, Social, and Environmental Factors Associated with Different Patterns of Stimulant Use: A Cross-Sectional Study from Five European Countries / $c M. Rosenkranz, A. O'Donnell, MS. Martens, H. Zurhold, P. Degkwitz, N. Liebregts, M. Barták, M. Rowicka, U. Verthein
520    9_
$a INTRODUCTION: Amphetamine-type stimulants (ATSs) are the second most commonly consumed class of illicit drugs globally, but there is limited understanding of the precise factors associated with problematic versus controlled ATS consumption. This exploratory study aimed to identify which individual, social, and environmental factors are associated with different patterns of ATS use over time. METHODS: Cross-sectional surveys were conducted in Germany, England, The Netherlands, Poland, and the Czech Republic via face-to-face computer-assisted personal interviews to collect data on different user groups. 1,458 adults (18+) reported exposure to but no ATS use (n = 339); former rare/moderate ATS use (n = 242); current rare/moderate ATS use (n = 273); former frequent/dependent ATS use (n = 201); current frequent/dependent ATS use (n = 403). Extent of ATS/other substance use was assessed by number of consumption days (lifetime, past year, past month) and Severity of Dependence Scale. To identify factors associated with group membership, data were also collected on previous injecting drug use (IDU) and consumption setting/rules. Psychological distress was measured using the Brief Symptom Inventory, with additional data collected on self-reported adverse life events and physical/mental health. RESULTS: Currently, using frequent/dependent ATS users experienced more frequent unstable living conditions (27.5%) and psychological distress (59.8%) compared to other groups. A multinomial logistic regression showed that currently abstinent rare/moderate users were more likely to abstain from methamphetamine use {odds ratio (OR) = 2.48 (confidence interval [CI] = 1.32-4.68)} and from IDU (OR = 6.33 [CI = 2.21-18.14]), to avoid ATS use during working hours (OR = 6.67 [CI = 3.85-11.11]), and not to use ATS for coping reasons (OR = 4.55 [CI = 2.50-6.67]) compared to the reference group of currently using frequent/dependent users. CONCLUSIONS: People who use ATS frequently and/or at dependent levels are more likely to have experienced social and economic adversity compared to infrequent ATS users. On the other hand, there is a substantial share of users, which show a controlled use pattern and are able to integrate ATS use into their lives without severe consequences.
650    _2
$a dospělí $7 D000328
650    _2
$a lidé $7 D006801
650    _2
$a průřezové studie $7 D003430
650    12
$a stimulanty centrálního nervového systému $x škodlivé účinky $7 D000697
650    _2
$a amfetamin $7 D000661
650    12
$a poruchy spojené s užíváním psychoaktivních látek $x psychologie $7 D019966
650    12
$a methamfetamin $7 D008694
655    _2
$a časopisecké články $7 D016428
700    1_
$a O'Donnell, Amy $u Population Health Sciences Institute, Faculty of Medical Science, Newcastle University, Newcastle, UK
700    1_
$a Martens, Marcus-Sebastian $u Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Zurhold, Heike $u Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Degkwitz, Peter $u Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Liebregts, Nienke $u Research and Documentation Centre (WODC), Ministry of Justice and Security, The Hague, The Netherlands
700    1_
$a Barták, Miroslav $u Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Rowicka, Magdalena $u Academy of Special Education, Institute of Applied Psychology, Maria Grzegorzewska University, Warsaw, Poland
700    1_
$a Verthein, Uwe $u Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
773    0_
$w MED00007942 $t European addiction research $x 1421-9891 $g Roč. 29, č. 3 (2023), s. 182-193
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37166303 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213094536 $b ABA008
999    __
$a ok $b bmc $g 2049760 $s 1211013
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 29 $c 3 $d 182-193 $e 20230425 $i 1421-9891 $m European addiction research $n Eur Addict Res $x MED00007942
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...